Page last updated: 2024-11-02

oxyphenbutazone and Eye Manifestations

oxyphenbutazone has been researched along with Eye Manifestations in 2 studies

Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.

Eye Manifestations: Ocular disorders attendant upon non-ocular disease or injury.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
James, DG2
Neville, E1
Langley, DA1
Siltzbach, LE1
Sharma, OP1
Carstairs, LS1

Other Studies

2 other studies available for oxyphenbutazone and Eye Manifestations

ArticleYear
Ocular sarcoidosis.
    Transactions of the ophthalmological societies of the United Kingdom, 1976, Volume: 96, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Chloroquine; Conjunctivitis; Eye Diseases; Eye Manifestations; Facia

1976
A tale of two cities: a comparison of sarcoidosis in London and New York.
    Archives of internal medicine, 1969, Volume: 123, Issue:2

    Topics: Adult; Age Factors; Black People; Chloroquine; Diagnosis, Differential; Eye Manifestations; Female;

1969